On Tuesday, Adma Biologics Inc (NASDAQ: ADMA) was 8.97% up from the session before settling in for the closing price of $14.71. A 52-week range for ADMA has been $13.50 – $25.67.
When this article was written, the company’s average yearly earnings per share was at 20.32%. With a float of $229.85 million, this company’s outstanding shares have now reached $238.33 million.
The extent of productivity of a business whose workforce counts for 685 workers is very important to gauge.
Adma Biologics Inc (ADMA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Adma Biologics Inc stocks. The insider ownership of Adma Biologics Inc is 3.42%, while institutional ownership is 86.41%. The most recent insider transaction that took place on Oct 24 ’25, was worth 336,000. In this transaction President and CEO of this company sold 21,000 shares at a rate of $16.00, taking the stock ownership to the 2,019,850 shares. Before that another transaction happened on Oct 24 ’25, when Company’s Director and Officer proposed sale 63,000 for $15.25, making the entire transaction worth $960,750.
Adma Biologics Inc (ADMA) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.14 earnings per share (EPS) during the time that was less than consensus figure (set at 0.15) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.32% per share during the next fiscal year.
Adma Biologics Inc (NASDAQ: ADMA) Trading Performance Indicators
You can see what Adma Biologics Inc (ADMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.81. Likewise, its price to free cash flow for the trailing twelve months is 93.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.85, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 0.91 in one year’s time.
Technical Analysis of Adma Biologics Inc (ADMA)
The latest stats from [Adma Biologics Inc, ADMA] show that its last 5-days average volume of 5.85 million was superior to 3.24 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 61.26%.
During the past 100 days, Adma Biologics Inc’s (ADMA) raw stochastic average was set at 34.91%, which indicates a significant decrease from 97.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.79 in the past 14 days, which was higher than the 0.66 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.30, while its 200-day Moving Average is $17.86. Now, the first resistance to watch is $16.50. This is followed by the second major resistance level at $16.97. The third major resistance level sits at $17.87. If the price goes on to break the first support level at $15.13, it is likely to go to the next support level at $14.23. Assuming the price breaks the second support level, the third support level stands at $13.76.
Adma Biologics Inc (NASDAQ: ADMA) Key Stats
There are 238,631K outstanding shares of the company, which has a market capitalization of 3.82 billion. As of now, sales total 426,450 K while income totals 197,670 K. Its latest quarter income was 134,220 K while its last quarter net income were 36,430 K.
